Stocks and Investing Stocks and Investing
Wed, May 22, 2019
[ 12:00 AM ] - WOPRAI
Jay Gelb Maintained (AFL) at Hold with Increased Target to $53 on, May 22nd, 2019
[ 12:00 AM ] - WOPRAI
Gary Hovis Upgraded (AES) to Strong Buy on, May 22nd, 2019
[ 12:00 AM ] - WOPRAI
Jason Seidl Upgraded (ARCB) to Buy on, May 22nd, 2019
Tue, May 21, 2019
[ 12:00 AM ] - WOPRAI
Craig Siegenthaler Upgraded (APO) to Buy and Increased Target to $42 on, May 21st, 2019
[ 12:00 AM ] - WOPRAI
Michael Phillips Maintained (ALL) at Hold with Increased Target to $100 on, May 21st, 2019
[ 12:00 AM ] - WOPRAI
Evan Seigerman Initiated (BIIB) at Sell and Held Target at $198 on, May 21st, 2019
[ 12:00 AM ] - WOPRAI
Michael Walkley Maintained (SWKS) at Strong Buy with Decreased Target to $90 on, May 21st, 2019
[ 12:00 AM ] - WOPRAI
Dennis McGill Upgraded (SWK) to Strong Buy on, May 21st, 2019
[ 12:00 AM ] - WOPRAI
Ben Kallo Maintained (TSLA) at Buy with Decreased Target to $23 on, May 21st, 2019
[ 12:00 AM ] - WOPRAI
Brad Erickson Initiated (BKNG) at Strong Buy on, May 21st, 2019
[ 12:00 AM ] - WOPRAI
Alex Kramm Upgraded (SPGI) to Strong Buy and Increased Target to $252 on, May 21st, 2019
[ 12:00 AM ] - WOPRAI
Greg Badishkanian Maintained (YUM) at Hold with Increased Target to $105 on, May 21st, 2019
[ 12:00 AM ] - WOPRAI
Arlinda Lee Initiated (XFOR) at Strong Buy and Held Target at $27 on, May 21st, 2019
Mon, May 20, 2019
[ 12:00 AM ] - WOPRAI
Simon Flannery Maintained (CCI) at Buy with Increased Target to $138 on, May 20th, 2019
[ 12:00 AM ] - WOPRAI
Simeon Gutman Upgraded (TGT) to Hold and Held Target at $67 on, May 20th, 2019
[ 12:00 AM ] - WOPRAI
David Toung Downgraded (BMY) to Hold on, May 20th, 2019
[ 12:00 AM ] - WOPRAI
Rajeev Lalwani Upgraded (UAL) to Buy and Increased Target to $110 on, May 20th, 2019
[ 12:00 AM ] - WOPRAI
Simon Flannery Maintained (AMT) at Hold with Increased Target to $201 on, May 20th, 2019
[ 12:00 AM ] - WOPRAI
Rajeev Lalwani Maintained (ALGT) at Hold with Decreased Target to $132 on, May 20th, 2019
[ 12:00 AM ] - WOPRAI
Rajeev Lalwani Maintained (ALK) at Buy with Increased Target to $81 on, May 20th, 2019
[ 12:00 AM ] - WOPRAI
Ross Gilardi Downgraded (AGCO) to Sell on, May 20th, 2019
[ 12:00 AM ] - WOPRAI
Pamela Kaufman Initiated (CAG) at Hold and Held Target at $31 on, May 20th, 2019
[ 12:00 AM ] - WOPRAI
Rajeev Lalwani Downgraded (AAL) to Sell and Decreased Target to $26 on, May 20th, 2019
[ 12:00 AM ] - WOPRAI
Rajeev Lalwani Downgraded (AAL) to Sell on, May 20th, 2019
[ 12:00 AM ] - WOPRAI
Brandon Oglenski Maintained (AAL) at Buy with Decreased Target to $48 on, May 20th, 2019
[ 12:00 AM ] - WOPRAI
Ross Sandler Maintained (BABA) at Buy with Increased Target to $225 on, May 20th, 2019
[ 12:00 AM ] - WOPRAI
Gregory Zhao Maintained (BIDU) at Hold with Decreased Target to $160 on, May 20th, 2019
[ 12:00 AM ] - WOPRAI
Jialong Shi Maintained (BIDU) at Hold with Decreased Target to $147 on, May 20th, 2019
Fri, May 17, 2019
[ 12:00 AM ] - WOPRAI
Jeff Kvaal Maintained (AAPL) at Hold with Decreased Target to $44 on, May 17th, 2019
[ 12:00 AM ] - WOPRAI
Martin Auster Upgraded (UTHR) to Hold and Decreased Target to $94 on, May 17th, 2019

Martin Auster Upgraded (UTHR) to Hold and Decreased Target to $94 on, May 17th, 2019


Published on 2024-10-26 13:48:00 - WOPRAI, Martin Auster
  Print publication without navigation


Martin Auster of UBS, Upgraded "United Therapeutics Corporation" (UTHR) to Hold and Decreased Target from $115 to $94 on, May 17th, 2019.

Martin has made no other calls on UTHR in the last 4 months.



There are 3 other peers that have a rating on UTHR. Out of the 3 peers that are also analyzing UTHR, 1 agrees with Martin's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • M. Auster of "Credit Suisse" Upgraded from Sell to Hold on, Thursday, May 9th, 2019


These are the ratings of the 2 analyists that currently disagree with Martin

  • Liana Moussatos of "Wedbush" Maintained at Buy with Increased Target to $273 on, Thursday, May 2nd, 2019
  • Geoff Meacham of "Barclays" Maintained at Sell with Decreased Target to $95 on, Friday, March 1st, 2019
Contributing Sources